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Abstract: Pathogens of bacterial and viral origin hijack pathways operating in eukaryotic 
cells in many ways in order to gain access into the host, to establish themselves and to 
eventually produce their progeny. The detailed molecular characterization of the 
subversion mechanisms devised by pathogens to infect host cells is crucial to generate 
targets for therapeutic intervention. Here we review recent data indicating that 
coronaviruses probably co-opt membranous carriers derived from the endoplasmic 
reticulum, which contain proteins that regulate disposal of misfolded polypeptides, for 
their replication. In addition, we also present models describing potential mechanisms that 
coronaviruses could employ for this hijacking. 
Keywords: coronaviruses; nidoviruses; double-membrane vesicles; MHV; SARS-
coronavirus; autophagy; EDEMosomes; EDEM1; OS-9; ERAD; ER quality control 
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1. Introduction 
Coronaviruses (CoV) are enveloped viruses with plus-strand RNA genomes belonging to the family 
Coronaviridae, which together with the Roni- and the Arteriviridae, form the order Nidovirales [1]. 
CoV infect a large range of birds and mammals, including humans, and their pathogenesis has been 
intensively studied since the 1960s. CoV generally cause respiratory and/or intestinal infections, 
although some may spread systemically. Human CoV (HCoV)-OC43 and HCoV-229E, for example, 
cause mild upper respiratory tract infections [2], although they are occasionally associated with severe 
pulmonary diseases in newborns and immuno-compromised people [3]. In spring 2003, a new human 
CoV became infamously notorious due to an outbreak in South East Asia and Canada [4,5]. The 
accused virus was rapidly identified as the SARS-CoV. Unlike HCoV-OC43 and -229E, the SARS-
CoV causes a severe respiratory disease [6], with nearly 10% mortality and it also spreads systemically 
[7]. Since 2003, two additional new human CoV have been characterized, i.e., HCoV-NL63 and 
HCoV-HKU-1, which are also mainly associated with mild upper respiratory tract infections [8-10].  
Several animal CoV are economically important pathogens [11]. For example, transmissible 
gastroenteritis virus (TGEV) causes diarrhea in pigs [12-14], feline infectious peritonitis virus (FIPV) 
leads to a fatal systemic disease in cats [15-17], the bovine coronavirus (BCoV) causes respiratory 
tract diseases and diarrhea in cattle [14,18] and the avian infectious bronchitis virus (IBV) is the 
etiological agent of severe respiratory tract and kidney diseases in chickens [14,19]. The mouse 
hepatitis virus (MHV) has been extensively used to study the replication and assembly of CoV in cell 
culture models as well as in whole animals and is thus considered as a prototype CoV [11,14]. 
2. CoV Life Cycle 
CoV virions are spherical enveloped particles, with a diameter of 70–120 nm [20]. All CoV 
particles contain a common set of 4 structural proteins, i.e., the spike (S), the membrane (M) and the 
envelope (E) transmembrane proteins, and the nucleocapsid (N) protein. The large genomic RNA is 
encapsidated by multiple copies of the N protein forming the helical nucleocapsid. The CoV envelope, 
which is composed of a lipid bilayer derived from host intracellular membranes, accommodates the 3 
transmembrane proteins. The S protein forms the peplomers that radiate from the virion surface. The 
M protein is the most abundant protein in the virus particle while the E protein is only present in small 
amounts [21,22]. 
The first step in the CoV infection cycle is the association of the virion with the host cell surface 
through the binding of the S proteins to specific receptors. After endocytic uptake, conformational 
changes in the S protein result in fusion of the viral envelope with a limiting cellular membrane [23-27]. 
Upon virus-cell fusion, the virions disassemble and release their genomic RNA in the cytoplasm. The 
viral RNA is directly translated into two very long polypeptides of approximately 400 and 800 kDa, 
called pp1a and pp1b, respectively [11,28,29]. During and after their synthesis, pp1a and pp1b are 
cleaved by viral proteinase activities contained in their sequence and this processing leads to the 
generation of 16 non-structural proteins (nsp’s) [11,30]. These factors probably trigger the 
rearrangement of host cellular membranes, resulting in the formation of a reticulovesicular network of 
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double membrane vesicles (DMVs) and convoluted membranes (Figure 1) and form replication-
transcription complexes (RTCs) that are associated with the rearranged membranes [31-35]. 
Figure 1. Ultrastructure of membrane-associated replicative structures induced by mouse 
hepatitis virus (MHV) in host cells. Mouse LR7 cells inoculated with the MHV-A59 strain 
were fixed at 10 h post-infection and processed for conventional EM. Double membrane 
vesicles (DMVs) are often found clustered together in close proximity of a small network 
of membranes, the CMs, which are morphologically distinct but have identical viral protein 
composition. The asterisks mark the DMVs. CM, convoluted membranes; M, 
mitochondria; L, lysosome. Size bar, 500 nm. 
 
 
The RTCs copy the genomic RNA either continuously into genome-length or discontinuously into 
various subgenome-length minus-strand templates. The minus strands are in turn used as templates for 
the synthesis of genomic and subgenomic mRNA [35,36]. These latter products comprise a nested set 
of overlapping species of mRNAs that extend for different lengths from a common 3' terminus [35,36]. 
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Replication and transcription of plus-strand RNA viruses result in the formation of double-stranded 
RNA (dsRNA) molecules that are generally assumed to function as intermediates in the RNA synthesis 
[36,38]. The exact location of viral RNA synthesis remains unknown at present. Although it has been 
shown that dsRNA accumulates in the interior of DMVs, the significance of this phenomenon remains 
unclear [31]. The dsRNA generated by viruses are potent inducers of antiviral interferon signaling 
pathways [39,40] and therefore its sequestration into DMVs could prevent the activation of these 
innate immune responses [31,38].  
The structural proteins are synthesized from the subgenomic RNAs and the ones with 
transmembrane segments are subsequently inserted in the limiting membrane of the endoplasmic 
reticulum (ER) [41-43]. The S protein is found along the secretory pathway and at the plasma 
membrane. The M protein, in contrast, localizes predominantly in the Golgi compartments while the E 
protein is detected in the ER, in the Golgi, and in the ER-to-Golgi intermediate compartment (ERGIC). 
Nonetheless, these proteins and the helical nucleocapsids cooperatively assemble into virions via 
lateral interactions that induce the invagination and luminal pinching off of the limiting membrane of 
the ERGIC. The resulting luminal virions subsequently reach the extracellular environment following 
the conventional secretory pathway. 
3. The ER Origin of the CoV-Induced DMVs 
All plus-strand RNA viruses synthesize their viral RNA in association with extensive virus-induced 
rearrangements of specific intracellular membranes. Different plus-strand RNA viruses may target 
different membrane compartments, such as the ER, endosomes, mitochondria or chloroplasts, thereby 
giving rise to membrane invaginations, (clusters of) DMVs or single-membrane vesicles, membrane-
bound vesicle packets, convoluted membranes and other structures or combinations thereof (for 
reviews see [38,44]). For a long time, the subcellular compartment from where the membranes 
composing the CoV-induced DMVs are derived has remained mysterious. The major difficulty in 
solving this issue has been the lack or the undetectable levels of marker proteins of subcellular 
organelles [33,45-47], the detection of which could have provided insight into the origin of these 
structures. Even so, several pieces of evidence has indicated that the ER is the most probable source 
for the lipid bilayers composing the CoV-induced DMVs. First, nsp3 and nsp4, two nonstructural 
proteins with transmembrane segments, which are very likely part of the RTCs, become 
N-glycosylated [48-51], a co-translational modification that occurs in the ER. Second, nsp4 localizes 
to the ER when ectopically expressed and moves to the DMVs upon viral infection [48]. Third, a block 
of the early transport steps of the secretory pathway inhibits CoV replication [46-48]. Fourth, 
ultrastructural studies where electron tomography was applied, demonstrated that the CoV-induced 
DMVs are interconnected via their outer membranes and are part of a membranous reticulovesicular 
network, which also includes convoluted membranes and is connected to the ER [31]. Fifth, Sec61α, 
which is a subunit of the ER translocon, redistributes upon SARS-CoV infection and localizes to the 
rearranged membranes [47]. Finally, the DMVs induced in SARS-CoV infected cells contain 
ribosomes on their outer membranes [31], although this has not been observed in MHV-infected  
cells [33,45]. 
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Even though the ER is the likely (possible) source of the membranes composing the CoV-induced 
DMVs, the lack of ER, ERGIC or Golgi protein markers, as well as the absence of coatomer proteins 
at their limiting membranes [31,33,46,47] question a model in which CoV co-opt ER-derived secretory 
vesicles for DMVs formation. Based on available data, it seems more plausible that DMVs might 
result from extensive modifications of ER membranes [47] or of ER-derived vesicles that regulate 
ERAD tuning, i.e., the export from the ER of EDEM1, OS-9 and other regulators of ER-associated 
degradation (ERAD) [45]. In the next sections, we will mainly review this latter scenario.  
4. ERAD, ERAD Tuning and its Subversion by CoV 
The ER is the site of maturation for secretory and membrane proteins in eukaryotic cells. Proteins 
that fail to attain the native structure must efficiently be removed from the ER lumen to protect cells 
from stress conditions eventually leading to cell death. Thus, besides molecular chaperones and 
folding enzymes that assist maturation of newly synthesized proteins, the ER also contains ERAD 
factors that recognize non-native proteins, extract them from the folding machineries and ensure their 
transport across the ER membrane for proteasomal degradation [52,53]. The intraluminal 
concentration of ERAD factors must be tightly regulated. When present in excess, ERAD factors 
might interfere with ongoing folding programs and trigger inappropriate degradation of not-yet-native 
folding intermediates. This might eventually compromise the ER capacity to efficiently produce 
functional polypeptides and may correlate, for example, with the enhancement of the metastatic 
potential of tumor cells caused by the inappropriate degradation of the newly synthesized metastatic 
repressor KAI1 occurring in cells with elevated concentration of the E3 ubiquitin ligase GP78 [54].  
Cumulating data hint at the important role for maintenance of ER homeostasis played by the 
post-translational regulation of ERAD factors content in the ER lumen (reviewed in [55]). This 
regulation has been named ERAD tuning [55] and consists in the rapid and selective removal from the 
ER lumen of ERAD regulators. Unlike conventional folding chaperones and enzymes, several ERAD 
regulators such as ERManI [56,57], EDEM1 [45,58,59], OS-9 [45], XTP3-B [60], HERP [61,62] and 
SEL1L [63] are in fact rapidly removed from the ER lumen in unstressed cells. Some of them are 
degraded by the proteasome [61-63]; others, such as the ERManI [56,57], EDEM1 [45,58,59] and OS-
9 [45] are degraded by endo-lysosomal enzymes.  
In 2007, Juergen Roth’s group revealed that EDEM1 is selectively released from the ER in 
vesicles [64]. More recently, we have shown that these carriers, which we have named EDEMosomes 
and display LC3/Atg8 at their limiting membrane, remove EDEM1 and other ERAD factors such as 
OS-9 from the ER lumen and transport them to endo-lysosomes for disposal (Figure 2) [45,58]. LC3 is 
a cytosolic ubiquitin-like protein that plays a crucial regulatory role in macroautophagy. Upon 
activation of this catabolic process that targets cellular components to lysosomes for degradation 
[65,66], LC3-I is converted into LC3-II by covalent conjugation to the membrane lipid 
phosphatidylethanolamine [67,68]. The covalent association of LC3-II to lipid bilayers appears to be 
essential to promote the elongation of the autophagosome membrane [69-71]. Interestingly, and unlike 
autophagosomes, the LC3-positive EDEMosomes are not decorated with ectopically expressed 
GFP-LC3 and do not contain LC3-II [58]. Rather, LC3-I is non-covalently associated to their limiting 
membrane and therefore this protein can be removed by carbonate extraction [59]. These results led us 
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to propose an unconventional, autophagy-independent use of LC3 for the vesicle-mediated removal of 
short-living chaperones from the ER lumen [58].  
Figure 2. ERAD tuning. Many ERAD regulators are short-lived proteins at steady state. 
EDEM1 and OS-9 are canonical ERAD tuning substrates. Their selective removal from the 
ER lumen can be subdivided in three steps. (1) Association with an elusive membrane 
receptor allows segregation of EDEM1, OS-9 and possibly other ERAD factors (EF) from 
conventional, long-lived ER-resident chaperones (in grey); (2) The ERAD regulators exit 
the ER in small, LC3-I-coated vesicles, the EDEMosomes; (3) EDEMosomes deliver their 
content to endo-lysosomal compartments for disposal.  
 
 
Significantly, the DMVs in cells infected with MHV or SARS-CoV share several analogies with the 
EDEMosomes since they also derive from the ER and display LC3-I, but not ectopically expressed 
GFP-LC3 or LC3-II, at their limiting membranes [31,45,72]. In agreement with these results, a 
non-lipidable form of LC3 associates with the MHV-induced DMVs [45]. The finding that in 
MHV-infected cells the turnover of EDEM1 and OS-9 is essentially stopped and that these two 
proteins accumulate in the DMVs (they actually are the only cellular factors that distinctly co-localize 
with MHV-induced DMVs in immuno-fluorescence analyses [45]) led us to propose that the 
mechanism regulating the formation of the EDEMosomes is co-opted by CoV to ensure their efficient 
replication [45]. In keeping with this assumption, as previously reported for ERAD tuning [58], an 
autophagy-independent function of LC3 supports CoV infection. In fact, while the macroautophagy 
machinery regulating the covalent association of LC3 to the autophagosomal membranes is 
dispensable for infection as demonstrated by normal replication of MHV in atg7−/− mouse embryonic 
fibroblasts (MEFs), the reduction of the intracellular levels of LC3 by siRNA efficiently interferes 
with MHV replication [45]. Interestingly, when endogenous LC3 is replaced with a non-lipidable form 
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of this protein, which cannot sustain autophagy, MHV infection is restored further supporting the 
notion of an unconventional use of LC3 in CoV replication. 
These data explain previous observations. Originally, it was reported that the ATG5 gene is 
essential for MHV replication in MEFs [73]. Careful reassessment of these findings in low passage 
atg5−/− MEFs and bone marrow derived macrophages lacking ATG5 by virtue of a Cre recombinase 
mediated gene deletion, revealed that an intact autophagy pathway is not required for MHV life 
cycle [74]. In addition, these data also reconcile previous contrasting reports about LC3 association 
with CoV-induced DMVs. The works describing a co-localization were analyzing endogenous LC3, 
while those affirming the contrary used ectopically expressed GFP-LC3 [72-77]. 
5. Unanswered Questions 
The rapid disposal of ERAD factors through the ERAD tuning and the hijacking of the ERAD 
tuning pathway by CoV are recent discoveries [45]. As a result, numerous questions still remain open. 
One scenario is that CoV anchor their replication and transcription complexes to the membranes of 
either EDEMosomes or “modified” EDEMosomes, whose fusion with a degradative endo-lysosomal 
compartment would be inhibited as a consequence of the infection. This would explain the defective 
EDEM1 and OS-9 turnover observed in infected cells and the enrichment of these two ERAD factors 
in the DMVs [45]. However, the molecular principles of the biogenesis of the EDEMosomes and 
DMVs are poorly understood (see above, [55,58,78,79]). In particular, the role of LC3-I in the 
formation of both EDEMosomes and CoV-induced DMVs remains unknown. One speculative idea is 
that LC3-I acts as a vesicle coat protein [79]. In such a scenario and similar to other vesicular transport 
pathways, one or more still elusive EDEMosome cargo receptors would bind EDEM1 and OS-9 in the 
ER lumen to segregate these short living ERAD factors from conventional and long-living molecular 
chaperones and folding enzymes. The cytosolic domain of this putative cargo receptor would then 
recruit cytosolic LC3-I. This latter step will be the key event required for the coat-driven formation of 
a carrier vesicle. Thus, one possible way for CoV to exploit the ERAD tuning machinery for 
generating their replicative DMVs would be to hijack one of the EDEMosome cargo receptors, 
perhaps by using one or more of their transmembrane non-structural proteins (i.e., nsp3, nsp4 and/or 
nsp6). Alternatively, these nsp’s could act more directly by recruiting LC3-I and other vesicle coating 
factors. The first option contemplates that EDEM1 and OS-9 end up in the DMVs through their 
association with the EDEMosome cargo receptor. The second does not explain the peculiar distribution 
of these two chaperones in the MHV-induced DMVs, but it could be consistent with a model claiming 
that CoV may actively sequester EDEMosome cargo proteins such as EDEM1 and OS-9 into the 
DMVs in order to weaken the ERAD capacity in the ER lumen of the host cell. At the peak of its 
replication, CoV induce ER stress due to a sustained high production of viral components [80-83], 
including the 3 integral membrane nsps and the 3 structural membrane proteins that are initially 
inserted in the ER lipid bilayer. One of the consequences of the induction of ER stress is the 
enhancement of ERAD. As this would hamper CoV replication by degrading viral products, 
sequestering EDEM1 and OS-9, two positive regulators of the ERAD process, could limit this cellular 
response that would interfere with viral replication.  
Viruses 2011, 3 
 
1617
LC3 could also play a role in ERAD tuning and/or viral replication by linking EDEMosomes and 
the CoV-induced DMVs to the microtubule network, a notion suggested by the original full-length 
name of this protein, i.e., microtubule-associated protein 1 light chain 3 (MAP1-LC3). The initial 
studies, revealed in fact that LC3 belongs to a family of microtubule-associated proteins and that it 
interacts with MAP1A or MAP1B to form a complex that binds and modulates the shape of 
microtubules [84-86]. Autophagosomes are mostly formed randomly at the periphery of the cell and 
redistribute in a microtubule-dependent way at the perinuclear region around the microtubule-
organizing center (MTOC) where the majority of late endosomes and lysosomes are concentrated  
[87-90]. Recently, one of the molecular bases that could regulate this trafficking event has been 
revealed by showing that the N-terminus of LC3 interacts with FYCO1 (FYVE and coiled-coil [CC] 
domain containing 1), which in turn could interact with kinesin(s) [91]. Depletion of FYCO1 or 
antibodies against the N-terminus of LC3 blocks the subcellular redistribution of autophagosomes after 
completion [87,91]. Similarly, LC3 could link the EDEMosomes and the CoV-induced DMVs to the 
microtubule network. Interestingly, the MHV replicative structures, when visualized by using a 
GFP-tagged version of nsp2, were shown to be transported along microtubules. Upon disruption of this 
cytoskeletal scaffold, these structures remain dispersed throughout the cytoplasm and fail to 
concentrate to the perinuclear region [92]. Connecting CoV-induced DMVs with microtubules, 
however, cannot be the only function of this protein during an infection because while microtubules 
are dispensable for MHV replication in culture cells [92], depletion of LC3 affects MHV  
replication [45]. 
Whatever scenario holds true, it remains unclear how the DMVs are shaped from the single-
membrane EDEMosome vesicles [79]. Furthermore, as EDEMosomes are probably derived from the 
smooth ER, it is not yet clear how to reconcile this with the observation that the surface of DMVs 
induced in SARS-CoV-infected cells is decorated with ribosomes [31], although ribosomes have not 
been observed on MHV-induced DMVs [33,45,79]. In addition, it remains to be solved how the 
alleged subversion of EDEMosomes by CoV results in the formation of a reticulovesicular network as 
observed in SARS-CoV infected cells [31].  
6. Perspectives 
Viruses are dependent on the host cell for virtually every step of the infection cycle and are able to 
subvert cellular processes to their own advantage. They can also be regarded as unique tools in cell 
biology research and have been used in the past decades to characterize a vast array of cellular 
machineries and pathways. Studying CoV replication and the biogenesis of the coronaviral replicative 
structures is therefore expected to increase our knowledge about the (re)shaping of cellular membranes 
and the formation of EDEMosomes, while the opposite also holds true. In addition, insight into 
virus-host interactions not only provides information into the cellular pathways hijacked by viruses, 
but also opens new avenues for therapeutic intervention. The absence of efficient anti-viral therapies 
emphasizes the necessity to further study and understand in detail the molecular mechanisms that 
regulate the CoV life cycle, including the role of LC3 in virus replication. This is desirable, as CoV are 
not only pathogens of veterinary importance, but a threat to mankind as well, as revealed by the 
emergence of the SARS-CoV. Furthermore, targeting of host rather than of viral proteins may, at least 
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in some cases, be advantageous as it is less likely to result in viral escape mutants, as in contrast to the 
viral proteins, cellular factors are not prone to rapid mutations.  
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